Interim Report 1 January - 31 March 2017

Report this content

"A strong start of the year"

1 JANUARY – 31 MARCH 2017 (3 MONTHS)

  • Net sales in the first quarter rose by 27 percent to SEK 576 million (453), of which organic growth totaled 12 percent and acquired growth totalled 14 percent.
  • EBITA rose by 53 percent to SEK 54 million (35) and EBITA-margin amounted to 9.3 percent (7.8).
  • Profit after tax rose by 54 percent and amounted to SEK 29 million (19).
  • Cash flow from operating activities amounted to SEK 47 million (15)
  • Earnings per share before dilution amounted to SEK 1.18 (0.95). For the 12-month period, earnings per share amounted to SEK 5.05 (4.15).
  • The equity ratio amounted to 40 percent (27).
  • Return on working capital (P/WC) amounted to 65 percent (64).
  • Two acquisitions have been carried out during the quarter with a combined annual sale of about SEK 195 million

Stockholm, April 28, 2017
AddLife AB (publ)
For more information, contact;
Kristina Willgård, CEO, kristina.willgard@add.life, +46 70 510 12 23
Martin Almgren, CFO, martin.almgren@add.life, +46 70 228 15 45
www.add.life

Teleconference
Investors. analysts and the media are invited to a teleconference at which CEO Kristina Willgård and CFO Martin Almgren will present the interim report. The presentation will be given in Swedish and take about 20 minutes. after which there will be an opportunity to ask questions.

The teleconference will be at 10:00 a.m. on 28 April 2017
The presentation will be available via the following link: https://5569958126.globalmeet.com/MartinAlmgren
Please call on: +46 8 22 90 90 code: 113242

AddLife is an independent player in the Life Science sector, offering high-quality products, services and advice to the private and public sectors, above all in the Nordic region. AddLife has about 600 employees in some 35 subsidiaries that operate under their own brands. The Group has annual sales of about
SEK 2.0 billion. AddLife shares are listed on Nasdaq Stockholm.


This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 a.m. CET on April 28.